These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 15537825
1. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear. Stiedl O, Meyer M, Jahn O, Ogren SO, Spiess J. J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825 [Abstract] [Full Text] [Related]
2. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety. Todorovic C, Radulovic J, Jahn O, Radulovic M, Sherrin T, Hippel C, Spiess J. Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007 [Abstract] [Full Text] [Related]
4. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system. Sherrin T, Todorovic C, Zeyda T, Tan CH, Wong PT, Zhu YZ, Spiess J. Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718 [Abstract] [Full Text] [Related]
5. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. de Groote L, Peñalva RG, Flachskamm C, Reul JM, Linthorst AC. J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348 [Abstract] [Full Text] [Related]
6. Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice. Tovote P, Meyer M, Ronnenberg A, Ogren SO, Spiess J, Stiedl O. Neuroscience; 2005 Jul; 134(4):1113-22. PubMed ID: 16039799 [Abstract] [Full Text] [Related]
7. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning. Sherrin T, Blank T, Saravana R, Rayner M, Spiess J, Todorovic C. Neuroscience; 2009 Aug 04; 162(1):14-22. PubMed ID: 19362130 [Abstract] [Full Text] [Related]
8. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures. Skórzewska A, Lehner M, Hamed A, Wisłowska-Stanek A, Turzyńska D, Sobolewska A, Płaźnik A. Behav Brain Res; 2011 Aug 01; 221(1):155-65. PubMed ID: 21376756 [Abstract] [Full Text] [Related]
9. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Lu L, Liu D, Ceng X, Ma L. Eur J Neurosci; 2000 Dec 01; 12(12):4398-404. PubMed ID: 11122350 [Abstract] [Full Text] [Related]
10. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF. J Pharmacol Exp Ther; 2004 Sep 01; 310(3):1027-34. PubMed ID: 15115804 [Abstract] [Full Text] [Related]
11. The localization of brain sites of anxiogenic-like effects of urocortin-2. Skórzewska A, Bidziński A, Lehner M, Turzyńska D, Sobolewska A, Wisłowska-Stanek A, Maciejak P, Szyndler J, Płaźnik A. Neuropeptides; 2011 Feb 01; 45(1):83-92. PubMed ID: 21168912 [Abstract] [Full Text] [Related]
12. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Staub DR, Evans AK, Lowry CA. Brain Res; 2006 Jan 27; 1070(1):77-89. PubMed ID: 16403469 [Abstract] [Full Text] [Related]
13. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats. Chu CP, Qiu DL, Kato K, Kunitake T, Watanabe S, Yu NS, Nakazato M, Kannan H. Regul Pept; 2004 Jun 15; 119(1-2):53-9. PubMed ID: 15093697 [Abstract] [Full Text] [Related]
14. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats. Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N. Pharmacol Biochem Behav; 2006 Oct 15; 85(2):435-40. PubMed ID: 17109941 [Abstract] [Full Text] [Related]
15. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, Vale WW, Sawchenko PE, Koob GF, Zorrilla EP. J Pharmacol Exp Ther; 2003 Apr 15; 305(1):385-93. PubMed ID: 12649393 [Abstract] [Full Text] [Related]
16. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. Radulovic J, Rühmann A, Liepold T, Spiess J. J Neurosci; 1999 Jun 15; 19(12):5016-25. PubMed ID: 10366634 [Abstract] [Full Text] [Related]
17. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine. Todorovic C, Jahn O, Tezval H, Hippel C, Spiess J. Neurosci Biobehav Rev; 2005 Jun 15; 29(8):1323-33. PubMed ID: 16099044 [Abstract] [Full Text] [Related]
18. The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures. Skórzewska A, Bidziński A, Hamed A, Lehner M, Turzyńska D, Sobolewska A, Maciejak P, Szyndler J, Wisłowska-Stanek A, Płaźnik A. Horm Behav; 2008 Nov 15; 54(5):602-12. PubMed ID: 18601929 [Abstract] [Full Text] [Related]
19. Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats. Gardiner SM, March JE, Kemp PA, Davenport AP, Wiley KE, Bennett T. J Pharmacol Exp Ther; 2005 Jan 15; 312(1):53-60. PubMed ID: 15328375 [Abstract] [Full Text] [Related]
20. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Sajdyk TJ, Fitz SD, Shekhar A. Stress; 2006 Mar 15; 9(1):21-8. PubMed ID: 16753930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]